Patient Characteristics and Risk Factors of Study Population (n = 45)
| No. of subjects | ||||
| Parameter | CT-positive | 18F-fluoride PET–positive | 18F-FDG PET–positive | Total study population |
| Subjects (n) | 34 (75.6) | 27 (60) | 34 (75.6) | 45 (100) |
| Age at risk | 28 (82.4) | 24 (88.9) | 27 (79.4) | 29 (64.4) |
| Male sex | 16 (47.1) | 12 (44.4) | 15 (44.1) | 21 (46.7) |
| Body mass index > 25 | 14 (41.2) | 9 (33.3) | 13 (38.2) | 17 (37.8) |
| Cardiovascular risk factors (n) | ||||
| Hypertension | 15 (44.1) | 12 (44.4) | 17 (50.0) | 18 (40.0) |
| Hypercholesterolemia | 11 (32.4) | 9 (33.3) | 10 (29.4) | 11 (24.4) |
| Diabetes mellitus | 3 (8.8) | 2 (7.4) | 3 (8.8) | 3 (6.7) |
| Smoking | 16 (47.1) | 13 (48.1) | 16 (47.1) | 17 (37.8) |
| Prior vascular event | 6 (17.6) | 5 (18.5) | 6 (17.6) | 6 (13.3) |
| Statin medication | 7 (20.6) | 7 (25.9) | 7 (20.6) | 7 (15.6) |
Values in parentheses are percentages.
Age at risk, 55 y or older for women or 45 y or older for men.